Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia

Next Previous
X
Search
Trial Profile

A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jul 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lefamulin (Primary) ; Moxifloxacin
  • Indications Bacterial infections; Community-acquired pneumonia
  • Focus Registrational; Therapeutic Use
  • Acronyms LEAP 2
  • Sponsors Nabriva Therapeutics

    • Most Recent Events

    • 15 Oct 2021 According to an Nabriva Therapeutics media release, Pooled Analysis from LEAP 1 and LEAP 2 Trials will be presented at CHEST 2021, the annual meeting of the American College of CHEST Physicians.
    • 01 Jun 2021 Results (n=310) a post-hoc analysis of adults with CABP managed as outpatients from the Lefamulin Evaluation Against Pneumonia(LEAP)2 study published in the Journal of Emergency Medicine
    • 16 Mar 2021 According to a Nabriva Therapeutics media release, results of the post-hoc analyses were published in The Journal of Emergency Medicine.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top